461 GLP-1RAs can suppress the activation of nuclear factor-kappa B (NF-B), a key transcription factor involved in the regulation of inflammatory processes
Comparison Protocol Semaglutide The foundational GLP-1 program for patients with significant weight to lose under standard dosing
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
Brussels: IDF
Mitochondria, the energy-producing powerhouses of cells, are also the primary intracellular site of oxygen consumption and the major source of reactive oxygen species (ROS)
Neuroprotective Research: Preclinical studies have shown that ghrelin and ghrelin receptor agonists can mitigate neuroinflammation, reduce vascular injury, and minimize neuronal apoptosis, suggesting potential applications beyond metabolic effects